Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Pacritinib versus best available therapy for low platelet Myelofibrosis

Dr John Mascarenhas - Mount Sinai School of Medicine New York, USA
Pacritinib versus best available therapy for low platelet Myelofibrosis ( Dr John Mascarenhas - Mount Sinai School of Medicine New York, USA )
6 Dec 2016

Dose escalation of CPI-613 with bendamustine for relapsed T Cell NHL

Dr Zanetta Lamar - Wake Forest Baptist Medical Center, Winston-Salem, USA
Dose escalation of CPI-613 with bendamustine for relapsed T Cell NHL ( Dr Zanetta Lamar - Wake Forest Baptist Medical Center, Winston-Salem, USA )
6 Dec 2016

ASH 2016 highlights: breaking new ground in haematology

Dr Giovanni Martinelli - Università di Bologna, Bologna, Italy
ASH 2016 highlights: breaking new ground in haematology ( Dr Giovanni Martinelli - Università di Bologna, Bologna, Italy )
6 Dec 2016

TCA cycle inhibition by CPI-613 increases chemo sensitivity in older AML patients

Dr Timothy Pardee - Wake Forest Baptist Medical Center, Winston-Salem, USA
TCA cycle inhibition by CPI-613 increases chemo sensitivity in older AML patients ( Dr Timothy Pardee - Wake Forest Baptist Medical Center, Winston-Salem, USA )
6 Dec 2016

Azacitidine plus nivolumab against acute myeloid leukaemia

Prof Naval Daver - MD Anderson Cancer Center, Houston, USA
Azacitidine plus nivolumab against acute myeloid leukaemia ( Prof Naval Daver - MD Anderson Cancer Center, Houston, USA )
6 Dec 2016

IKZF1 mutations associated with paediatric ALL

Dr Michelle Churchman - St. Jude Children's Research Hospital, Memphis, USA
IKZF1 mutations associated with paediatric ALL ( Dr Michelle Churchman - St. Jude Children's Research Hospital, Memphis, USA )
5 Dec 2016

Rituximab after ASCT prolongs survival for young MCL patients

Prof Steven Le Gouill - Nantes Medical University, Nantes, France
Rituximab after ASCT prolongs survival for young MCL patients ( Prof Steven Le Gouill - Nantes Medical University, Nantes, France )
5 Dec 2016

Highlights in myeloid leukaemia research from ASH 2016

Dr Luca Mazzarella - European Institute of Oncology, Milan, Italy
Highlights in myeloid leukaemia research from ASH 2016 ( Dr Luca Mazzarella - European Institute of Oncology, Milan, Italy )
5 Dec 2016

Thromboembolytic risks of central venous catheters in paediatric patients

Dr Julie Jaffray - Children's Center for Cancer, Los Angeles, USA
Thromboembolytic risks of central venous catheters in paediatric patients ( Dr Julie Jaffray - Children's Center for Cancer, Los Angeles, USA )
5 Dec 2016

Pure erythroid leukaemias

Dr Guillermo Montalbán Bravo - MD Anderson Cancer Center, Houston, USA
Pure erythroid leukaemias ( Dr Guillermo Montalbán Bravo - MD Anderson Cancer Center, Houston, USA )
5 Dec 2016

Clinical updates for guadecitabine and vorinostat

Dr Guillermo Montalbán Bravo - MD Anderson Cancer Center, Houston, USA
Clinical updates for guadecitabine and vorinostat ( Dr Guillermo Montalbán Bravo - MD Anderson Cancer Center, Houston, USA )
5 Dec 2016

Advances in CLL from ASH 2016

Prof Stephan Stilgenbauer, Prof Clemens-Martin Wendtner, Prof Steven Coutre And Dr Jeffery Jones
Advances in CLL from ASH 2016 ( Prof Stephan Stilgenbauer, Prof Clemens-Martin Wendtner, Prof Steven Coutre And Dr Jeffery Jones )
5 Dec 2016